CXCR2及其配体与肿瘤关系研究进展
2017-11-14袁瑞研王许安刘颖斌
袁瑞研+王许安+刘颖斌
摘 要: CXC受体2(CXC receptor 2,CXCR2)是多种趋化因子受体,与机体的炎症免疫过程密切相关。近年来,随着炎症免疫在肿瘤中的研究进一步深入,发现CXCR2与其配体相互作用形成多种信号轴,共同在胰腺癌、乳腺癌、结直肠癌等多种恶性肿瘤的肿瘤微环境构建与调控中发挥重要作用,对肿瘤的血管生成、肿瘤细胞的增殖、转移、侵袭以及上皮细胞间质转化等方面均有明显影响与调控作用。
关键词 肿瘤;炎症;免疫;CXCR2;趋化因子
中图分类号:R73 文献标志码:A 文章编号:1006-1533(2017)20-0003-05
Research progress of relationship between cancer and CXCR2 along with its ligands
YUAN Ruiyan, WANG Xuan, LIU Yingbin
(Department of General Surgery, Xinhua Hospital affiliated to School of Medicine, Shanghai Jiao Tong University, Shanghai 200092, China)
ABSTRACT: CXC receptor 2(CXCR2 )is the receptor of various chemokines, which is closely connected with bodys inflammation and immunity. Recently, with the further research of inflammation and immunity in cancer, it is shown that the interaction of CXCR2 and its ligands works like all kinds of signaling axes and that plays an important role in both construction and modification of tumor microenvironment in many malignant cancers, such as pancreatic cancer, breast cancer, colorectal cancer and so on. CXCR2 axis has obvious impact and regulation on tumor angiogenesis, proliferation, metastasis, invasion and epithelial-mesenchymal transition of tumor cells.
KEY WORDS neoplasms; inflammation; immunity; CXCR2; chemokines
CXC受體2(CXC receptor 2,CXCR2)属于G蛋白偶联受体家族,其配体为CXCL1(C-X-C motif chemokine ligand 1)、CXCL2、CXCL3、CXCL5、CXCL6、CXCL7、CXCL8等多种CXC类趋化因子[1]。早期研究发现,CXCR2可募集中性粒细胞向炎症区域转移[2-3],认为与炎症免疫相关。近年发现,CXCR2参与多种肿瘤的发生、发展、治疗过程,CXCR2轴在肿瘤微环境中的作用越来越得到重视。
CXCR2家族可促进结肠癌[4]、鳞状细胞癌[5]的发生,能调节胰腺导管腺癌髓源性抑制细胞(myeloidderived suppressor cells,MDSC)的转移[1],促进乳腺癌细胞转移和侵袭[6-7],以及上皮细胞间质转化(epithelialmesenchymal transition,EMT)[8],对肿瘤微环境的构建发挥着重要作用。同时,在乳腺肿瘤、胰腺癌中具有促血管生成作用[9]。治疗方面,研究发现CXCR2在胰腺导管腺癌[1]以及化疗耐药乳腺癌[6]治疗中可能是重要的切入点。
1 CXCR2及其配体的结构与功能
1.1 CXCR2的结构
CXCR2是CXC类趋化因子所对应受体家族的一员,常分布于中性粒细胞,亦可见于肥大细胞、巨噬细胞、内皮细胞及多种肿瘤细胞,因其能与白细胞介素(IL)-8高亲和力特异结合,故又称IL8Rβ(interleukin 8 receptor,beta)。CXCR2编码基因位于染色体2q33-q36,受体蛋白约由350个氨基酸组成[10]。……
